Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Harvard Business School
Dow
Novartis
Queensland Health
Mallinckrodt
Fish and Richardson
Cipla
Julphar

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,647,447

« Back to Dashboard

Summary for Patent: 4,647,447
Title: Diagnostic media
Abstract:A diagnostic medium contains at least one physiologically well tolerated complex salt comprising an anion of a complexing acid and one or more central ion or ions of an element with an atomic number of 21 to 29, 42, 44 or 57 to 83 and, optionally, one or more physiologically biocompatible cation or cations of an inorganic and/or organic base or amino acid, optionally, with additives customary in galenic formulations, dissolved or suspended in an aqueous medium.
Inventor(s): Gries; Heinz (Berlin, DE), Rosenberg; Douwe (Berlin, DE), Weinmann; Hanns-Joachim (Berlin, DE)
Assignee: Schering Aktiengesellschaft (Berlin and Bergkamen, DE)
Application Number:06/573,184
Patent Claim Types:
see list of patent claims
Use; Dosage form; Composition; Compound;

Drugs Protected by US Patent 4,647,447

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,647,447

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3129906Jul 24, 1981
Germany3302410Jan 21, 1983

International Patents Family Members for US Patent 4,647,447

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 18719 ➤ Try a Free Trial
Austria 397465 ➤ Try a Free Trial
Austria 52247 ➤ Try a Free Trial
Austria A19184 ➤ Try a Free Trial
Australia 1018488 ➤ Try a Free Trial
Australia 1018688 ➤ Try a Free Trial
Australia 2355984 ➤ Try a Free Trial
Australia 566007 ➤ Try a Free Trial
Australia 574658 ➤ Try a Free Trial
Australia 601916 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Colorcon
Cipla
UBS
QuintilesIMS
Fish and Richardson
Moodys
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot